复星医药(02196)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02196 复星医药

已收盘 09-29 16:08:04

17.870

+0.230

+1.30%

最高18.150	最低17.690	成交量296.86万
今开17.860	昨收17.640	日振幅2.61%
总市值473.20亿	流通市值94.71亿	总股本26.48亿
成交额5,310万	换手率0.56%	流通股本5.30亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02196","market":"HK","secType":"STK","nameCN":"复星医药","latestPrice":17.87,"timestamp":1790669284003,"preClose":17.64,"halted":0,"volume":2968591,"delay":0,"changeRate":0.013038548752834491,"floatShares":530000000,"shares":2648000000,"eps":1.4856838776999306,"marketStatus":"已收盘","change":0.23,"latestTime":"09-29 16:08:04","open":17.86,"high":18.15,"low":17.69,"amount":53100177,"amplitude":0.026077,"askPrice":17.87,"askSize":30000,"bidPrice":17.83,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":1.497391534588136,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790731800000},"marketStatusCode":5,"adr":0,"listingDate":1351526400000,"exchange":"SEHK","adjPreClose":17.64,"dividendRate":0.025525,"openAndCloseTimeList":[[1790645400000,1790654400000],[1790658000000,1790668800000]],"volumeRatio":1.424379,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600196","market":"SH","secType":"STK","nameCN":"复星医药","latestPrice":23.39,"timestamp":1790665200000,"preClose":23.24,"halted":0,"volume":29058000,"delay":0,"premium":"-34.69"}},"requestUrl":"/m/hq/s/02196","defaultTab":"news","newsList":[{"id":"2671251705","title":"股市必读：复星医药新发布《复星医药H股公告-翌日披露报表》","url":"https://stock-news.laohu8.com/highlight/detail?id=2671251705","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671251705?lang=zh_cn&edition=full","pubTime":"2026-09-29 01:12","pubTimestamp":1790615537,"startTime":"0","endTime":"0","summary":"公司公告汇总复星医药H股公告-翌日披露报表上海复星医药(集团)股份有限公司于2026年9月25日购回62,000股H股股份，每股购回价介乎17.34港元至17.47港元，总代价为1,080,535港元。该等股份拟持作库存股份。本次购回在联交所进行，占购回前已发行股份的0.01%。复星医药关于2025年A股股票期权激励计划预留授予结果公告上海复星医药（集团）股份有限公司已完成2025年A股股票期权激励计划的预留授予登记工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900001550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","600196","BK0060","BK0188","BK0239","BK1593","BK0187","BK0196","BK1191","BK0096","BK1515","BK0012","BK0183","02196","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133323834","title":"复星医药公布2025年A股期权激励计划预留授予结果 共计授予72.33万份期权","url":"https://stock-news.laohu8.com/highlight/detail?id=1133323834","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133323834?lang=zh_cn&edition=full","pubTime":"2026-09-28 17:21","pubTimestamp":1790587292,"startTime":"0","endTime":"0","summary":"公司已完成2025年A股股票期权激励计划的预留授予及登记工作。本次实际向99名激励对象授予A股期权合计723,300份，授予日为2026年8月28日，行权价为人民币27.93元/股，股票来源为公司已/将从二级市场回购的A股库存股份。期权代码为1000001131和1000001132。第二个行权期为自预留授予日起满24个月后的首个交易日至36个月的最后一个交易日，可行权数量占50%。复星医药表示，未满足行权条件或在行权期内未行权的期权将被注销。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670240219","title":"复星医药于9月25日斥资108.05万港元回购6.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2670240219","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670240219?lang=zh_cn&edition=full","pubTime":"2026-09-28 08:27","pubTimestamp":1790555220,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端复星医药（02196）发布公告，于2026年9月25日，该公司斥资108.05万港元回购6.2万股。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-09-28/doc-initirzp9728819.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","BK1593","BK0175","BK0060","BK1515","02196","BK0183","BK0028","BK0096","BK0196","BK0187","BK0188","600196","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670381409","title":"股市必读：复星医药新发布《复星医药关于控股子公司签订合作与许可协议的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2670381409","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670381409?lang=zh_cn&edition=full","pubTime":"2026-09-28 01:12","pubTimestamp":1790529134,"startTime":"0","endTime":"0","summary":"公司公告汇总：复星医药于9月24日及25日连续两日实施H股回购，合计购回134,000股，总代价约235万港元，均拟作库存股份。公司公告汇总复星医药关于控股子公司签订合作与许可协议的公告2026年9月23日，复星医药控股子公司复宏汉霖与Amberstone签订《合作与许可协议》，获得基于T-MATE技术平台针对两个靶点开发两款T细胞衔接器产品的全球独家许可。本次购回在联交所进行，占购回前已发行股份的0.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800000761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK1593","02196","BK0175","BK0239","BK0183","BK0028","600196","BK0196","BK0188","BK0012","BK1515","BK0096","BK0060","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132261546","title":"复星医药：贝莱德减持，好仓比例降至5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=1132261546","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132261546?lang=zh_cn&edition=full","pubTime":"2026-09-25 17:51","pubTimestamp":1790329892,"startTime":"0","endTime":"0","summary":"贝莱德于2026年9月22日以非现金资产场外减持复星医药H股288.83万股，属场外交易（代价性质：非现金资产），未经联交所公开市场撮合，不属二级市场直接买卖。贝莱德此次减持前持有复星医药好仓3477.57万股，占比6.3%；减持后持股量为3188.74万股，好仓比例降至5.78%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165092582","title":"复星医药：9月25日回购6.2万股，耗资约108.05万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1165092582","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165092582?lang=zh_cn&edition=full","pubTime":"2026-09-25 17:11","pubTimestamp":1790327500,"startTime":"0","endTime":"0","summary":"上海复星医药（集团）股份有限公司于2026年9月25日公告称，公司当天在香港联交所场内回购普通H股62,000股，约占该次回购前已发行股份总数的0.01%。每股回购价格介乎港币17.34元至17.47元，合计支付约108.05万港元。截至目前，公司已累计回购11,364,500股，占购回授权获通过当日已发行股份总数的2.1%。公司确认已遵守相关上市规则及适用法规要求。购回相关股份后30日内，公司将暂停在市场上增发新股或出售库藏股份。本次公告由公司董事陈玉卿签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"复星医药：9月25日回购6.2万股，耗资约108.05万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192213821","title":"复星医药：9月24日回购72,000股股份，总额约126.95万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1192213821","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192213821?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:22","pubTimestamp":1790241731,"startTime":"0","endTime":"0","summary":"复星医药于2026年9月24日发布公告，公司当日在香港联交所场内回购H股共72,000股，占本次回购前公司已发行股本约0.01%。每股回购价介乎港币17.59元至17.67元，合计支付价款港币1,269,510元。截至目前，公司已根据该授权回购股份累计达11,302,500股，占授权通过当日公司已发行股本总数约2.09%。本次回购完成后，公司预计将遵守有关规定，在2026年10月24日之前暂停任何新股发行或库藏股出售、转让的安排。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"复星医药：9月24日回购72,000股股份，总额约126.95万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669650274","title":"复星医药(02196)9月24日斥资126.95万港元回购7.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669650274","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669650274?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:17","pubTimestamp":1790241426,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(02196)发布公告，于2026年9月24日斥资126.95万港元回购7.2万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1500499.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1191","BK0028","BK0183","BK1593","600196","BK0012","02196","BK0096","BK0187","BK0188","BK0239","BK0175","BK0196","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157839983","title":"复星医药(02196)子公司复宏汉霖获Amberstone全球独家T-MATE™技术许可 最高付款或达23,616万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1157839983","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157839983?lang=zh_cn&edition=full","pubTime":"2026-09-23 17:52","pubTimestamp":1790157153,"startTime":"0","endTime":"0","summary":"2026年9月23日，复星医药发布海外监管公告称，其控股子公司上海复宏汉霖生物技术股份有限公司与Amberstone Biosciences, Inc.签署《合作与许可协议》，获得基于T-MATE技术平台、针对约定2个靶点的两款T细胞衔接器产品在全球范围及所有人类用途领域内的独家开发、生产及商业化许可，并可再授权。Amberstone成立于2018年12月，注册地美国特拉华州，董事长兼CEO为George Wu。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669935109","title":"复星医药：复宏汉霖获Amberstone授予独家许可，协议包含至多2.36亿美元的总付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2669935109","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669935109?lang=zh_cn&edition=full","pubTime":"2026-09-23 16:38","pubTimestamp":1790152732,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["02196","BK0239","HK0000320223.HKD","BK0175","BK0188","BK0060","BK0096","BK0196","BK1161","BK0028","HK0000306701.USD","BK1191","BK0012","HK0000165453.HKD","BK0183","HK0000306685.HKD","BK1515","HK0000320264.USD","02696","600196","BK0187","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158774134","title":"复星医药9月22日回购120万股股份，耗资约2,179.16万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158774134","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158774134?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:42","pubTimestamp":1790070126,"startTime":"0","endTime":"0","summary":"复星医药于2026年9月22日发布公告称，公司当日在香港联交所回购1,200,000股H股，占回购前已发行股份总数约0.23%。回购价格介于每股18.01港元至18.23港元，总涉资约2,179.16万港元。本次回购后，公司已发行股份总数减至529,741,000股，库藏股数量增至22,199,500股。此前，公司于2026年6月16日召开的股东大会上通过了回购授权，授权回购股份总数为54,097,150股。公告同时指出，公司已按照香港联交所上市规则及相关法规合规开展本次回购事宜。公告由董事陈玉卿签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"复星医药9月22日回购120万股股份，耗资约2,179.16万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669486721","title":"复星医药(02196.HK)9月22日斥资2179.16万港元回购120万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669486721","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669486721?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:40","pubTimestamp":1790070038,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","BK1593","02196","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115112298","title":"复星医药：控股股东解除约9903万股质押股份 质押比例降至62.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=1115112298","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115112298?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:55","pubTimestamp":1789984547,"startTime":"0","endTime":"0","summary":"2026年9月21日，复星医药公告称，控股股东上海复星高科技（集团）有限公司于2026年9月18日办理完成部分A股股份解除质押。涉及股份数量为99,025,000股，占复星高科技持股总数的10.30%，占公司截至2026年9月18日收市股份总数的3.71%。本次操作后，复星高科技持有复星医药股份总数为961,424,455股，其中A股889,890,955股、H股71,533,500股，持股比例维持36.00%。公告称，复星高科技后续仍存在对相关股份再质押的计划，未来如发生新的质押事宜，将按法规及时披露。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191127809","title":"复星医药9月21日回购27.15万股，耗资约486.23万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191127809","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191127809?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:36","pubTimestamp":1789983362,"startTime":"0","endTime":"0","summary":"2026年9月21日，复星医药发布翌日披露报表，公告该公司于当日在香港联交所场内回购H股普通股，涉及股份数量为27.15万股，占公司现有已发行股本约0.05%。根据公告，本次回购价格区间为每股17.78港元至17.98港元，合计耗资约486.23万港元。公司于2026年6月16日通过回购授权，授权可回购股份总数为54,097,150股。按照有关规定，在此次回购后的一段时间内，公司将暂不进行新的股份发行或出售、转让任何库藏股，暂止期至2026年10月21日。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"复星医药9月21日回购27.15万股，耗资约486.23万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669154429","title":"复星医药：9月21日斥资486.23万港元回购27.15万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669154429","media":"南方财经网","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669154429?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:35","pubTimestamp":1789983300,"startTime":"0","endTime":"0","summary":"南财智讯9月21日电，复星医药（02196.HK）发布翌日披露报表，公司于2026年9月21日在香港联交所进行股份回购，回购股份数量为271500股，每股最高回购价17.98港元，每股最低回购价17.78港元，付出的总代价为4862335港元。该等回购股份拟持作库存股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609213880099430.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609213880099430.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","BK0028","BK0060","600196","BK0196","02196","BK0188","BK0012","BK0096","BK0239","BK0183","BK1191","BK0187","BK0175","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669596251","title":"复星医药：控股股东复星高科技解除质押9902.50万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669596251","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669596251?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:33","pubTimestamp":1789979580,"startTime":"0","endTime":"0","summary":"南财智讯9月21日电，复星医药公告，公司于2026年9月21日接到控股股东上海复星高科技（集团）有限公司通知，其已将所持有的公司99,025,000股A股办理解除质押手续，解除质押时间为2026年9月18日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609213880040762.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609213880040762.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0188","BK0196","BK1593","BK0028","BK0183","BK0096","BK1191","600196","BK0012","BK1515","BK0060","02196","BK0239","BK0175","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669509139","title":"医美概念股多股上扬 三生制药（01530）涨5.71%、四环医药（00460）涨4.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669509139","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669509139?lang=zh_cn&edition=full","pubTime":"2026-09-21 10:09","pubTimestamp":1789956581,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股医美概念股多股上扬，截至发稿，山东新华制药股份 涨10.81%，三生制药涨5.71%，四环医药涨4.17%，昊海生物科技涨3.82%，复星医药涨3.12%，现代牙科涨3.10%，时代天使涨2.25%。消息面上，国金证券表示，医美板块下游连锁景气回暖，上游平台化逻辑有望兑现，建议关注上游头部连锁化机构、需求扩容下具备强渠道能力的上游平台化标的。看好布局差异化赛道的上游医美产品厂商及满足医美新场景需求的下游医美机构。","market":"other","thumbnail":"https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992051","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03600","06699","06826","BK1100","00460","BK1515","02196","BK1593","01530","BK1600","BK1583","BK1161","HK0000165453.HKD","BK1587","BK1191","00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147791636","title":"复星医药：控股股东复星高科技新增质押2.25亿股并同步解押2.20亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1147791636","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147791636?lang=zh_cn&edition=full","pubTime":"2026-09-18 17:12","pubTimestamp":1789722738,"startTime":"0","endTime":"0","summary":"复星医药9月18日在香港联交所发布海外监管公告，披露控股股东上海复星高科技（集团）有限公司于2026年9月17日办理股份质押及解除质押事宜。复星高科技本次新增质押2.25亿股A股，质押起始日为2026年9月17日，到期日为2028年9月21日，质权人为中国工商银行股份有限公司上海市长宁支行。同日，复星高科技解除质押2.2025亿股A股，占其所持股份的22.91%，占公司总股本的8.25%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122876585","title":"复星医药：9月18日回购130万股，耗资约2,277.01万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1122876585","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122876585?lang=zh_cn&edition=full","pubTime":"2026-09-18 17:05","pubTimestamp":1789722348,"startTime":"0","endTime":"0","summary":"上海复星医药（集团）股份有限公司于2026年9月18日发布公告，披露当日于香港联交所场内回购1,300,000股H股，占回购前公司已发行股份总数约0.24%。本次回购每股价格介乎港币17.35元至17.58元，总耗资约港币22,770,110元。公告显示，本次回购完成后，公司已发行股份数仍为551,940,500股；其中已发行股份为531,212,500股，库藏股为20,728,000股。公司并披露，本次回购股份后再进行新股发行或出售库藏股的暂止期截至2026年10月18日。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"复星医药：9月18日回购130万股，耗资约2,277.01万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668413439","title":"复星医药(02196.HK)9月18日斥资2277.01万港元回购130万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2668413439","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668413439?lang=zh_cn&edition=full","pubTime":"2026-09-18 16:57","pubTimestamp":1789721871,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02196","BK1191","BK1515","BK1593"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fosunpharma.com","stockEarnings":[{"period":"1week","weight":-0.0355},{"period":"1month","weight":0.0691},{"period":"3month","weight":0.1992},{"period":"6month","weight":-0.1144},{"period":"1year","weight":-0.2634},{"period":"ytd","weight":-0.0731}],"compareEarnings":[{"period":"1week","weight":-0.016},{"period":"1month","weight":-0.0368},{"period":"3month","weight":0.077},{"period":"6month","weight":-0.0258},{"period":"1year","weight":-0.0569},{"period":"ytd","weight":-0.0385}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海复星医药（集团）股份有限公司是一家主要从事医药产品研发、制造与销售的中国公司。该公司通过五个分部开展业务。制药分部主要从事药品的研发、生产和销售。医疗器械与医学诊断分部主要从事医疗器械和诊断产品的研发、生产和销售。医疗健康服务分部主要从事提供医疗健康服务及医院管理。医药分销和零售分部主要从事医药、器械分销和零售。 该公司还运营其他分部。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.044495},{"month":2,"riseRate":0.714286,"avgChangeRate":0.036179},{"month":3,"riseRate":0.571429,"avgChangeRate":0.044259},{"month":4,"riseRate":0.357143,"avgChangeRate":0.026},{"month":5,"riseRate":0.428571,"avgChangeRate":0.024935},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.032656},{"month":7,"riseRate":0.642857,"avgChangeRate":0.03393},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.040558},{"month":9,"riseRate":0.5,"avgChangeRate":0.018154},{"month":10,"riseRate":0.461538,"avgChangeRate":0.020365},{"month":11,"riseRate":0.428571,"avgChangeRate":0.034477},{"month":12,"riseRate":0.428571,"avgChangeRate":0.015129}],"exchange":"SEHK","name":"复星医药","nameEN":"FOSUN PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"复星医药(02196)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供复星医药(02196)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"复星医药,02196,复星医药股票,复星医药股票老虎,复星医药股票老虎国际,复星医药行情,复星医药股票行情,复星医药股价,复星医药股市,复星医药股票价格,复星医药股票交易,复星医药股票购买,复星医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"复星医药(02196)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供复星医药(02196)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}